Author

Elizabeth Babu

Washington University in St. LouisORCID 0000-0002-0305-0412Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Andrea R. HagemanniD· 1 shared Benjamin Guy BitleriD· 1 shared Bisiayo FashemiiD· 1 shared Brooke E. SandersiD· 1 shared Carolyn Kay McCourtiD· 1 shared David Gardner MutchiD· 1 shared Dineo KhabeleiD· 1 shared Ian S. HagemanniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andrea R. HagemannORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintSep 24, 2025

Targeting RAD52 overcomes PARP inhibitor resistance in preclinical Brca2-deficient ovarian cancer model

Yukihide Ota, Vijayalaxmi G. Gupta, Bisiayo Fashemi…·Dineo Khabele

This study identifies RAD52 as a target to overcome PARP inhibitor resistance in BRCA2-deficient ovarian cancer by showing its role in DNA repair and demonstrating synergistic effects with PARP inhibitors.

DOI 10.1101/2025.09.24.678351

mousebulk RNA-seq

𝕏 PostBluesky